In May, Kymos expanded again its facilities with new Analytical Development and Biopharmaceutical Testing laboratories. During the year, batch testing services for biosimilars and Asian clients are driving the company growth.


In July, Kymos expanded its facilities moving the offices to a new free-standing building close to the existing one. This new building has a training room, an archive, different meeting rooms and a cafeteria.

Kymos offices


In July, Kymos underwent a general site inspection by the FDA. The inspection was completed succesfully and the corresponding EIR letter was issued.



In November 2016, the company acquired a CRO in Italy called PHARMAPROGRESS. The company was located in Ancona and had 8 people on staff. This company had a 700 m2 of laboratories for bioanalysis and analytical development of APIs and DPs. Nowadays, the company has been fully integrated into KYMOS and now has 16 people on staff.

Pharmaprogress façade


In January 2015, the company moved its facilities from Barcelona (Barcelona Science Park) to a free-standing buiding in Cerdanyola del Vallès (Vallès Technology Park). A brand-new laboratory was built, increasing the surface area from 650 m2 to 1,500 m2. This meant the company could boost turnover and grow its staff in 2015 and 2016. The same year KYMOS obtained the importation autorization for medicinal products. Batch release services for marketing products were implemented.

Kymos site


In January 2012, KYMOS reached an agreement to take over the immunology department of a former R&D centre that French multinational group IPSEN had in Barcelona. Thanks to this deal, KYMOS was able to create a new biological division. Experienced staff, instruments and know-how were transferred to Kymos and both companies signed a long-term collaboration agreement to develop innovative drugs jointly.

Ipsen&Kymos contract signature


In 2011, KYMOS built a microbiology laboratory and extended its GMP certification to microbiological testing of non-sterile products. This certification was later extended further to cover sterile products in 2016.

Kymos 2011 team


In 2009, the company obtained GMP and Manufacturer authorization (partial manufacturer for quality control activities). From this point, KYMOS moved all CMC activities (mainly analytical development and stability studies) to GMP quality system and begun to provide quality control services for APIs and DPs.

GMP certificate


The company obtained the GLP certification in 2002, at the very beginning. The first projects were in metabolism and bioanalysis. 


KYMOS was founded in 2001 by a group of professionals with more than 10 years of experience in research and deveelopment in the pharmaceutical industry. The staff members were clients before being suppliers, acquiring extensive knowledge of the pharma company requirements and priorities. This experience allowed KYMOS to start-up the company quicly, despite being in this highly competitive market. The company was initially established in Barcelona Science Park, expanding from one to four different labs in just few years.

Kymos foundation team